Targeting Epigenetic Proteins to Prevent Breast Cancer

News   Jun 20, 2018 | Original story from Rockerfeller University

 
Targeting Epigenetic Proteins to Prevent Breast Cancer

The epigenetic regulatory protein DNA methyltransferase 1 (green) is highly expressed in the luminal cells of mammary gland ducts (compared with basal cells, red). Treatment with the inhibitor decitabine (right) prevents luminal cell progenitors from expanding this population of cells in response to progesterone. Credit: Casey et al., 2018

 
 
 

RELATED ARTICLES

Hay Fever Risk Genes Overlap with Autoimmune Disease

News

In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.

READ MORE

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Allergic Responses May Protect Against Skin Cancer

News

The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy